Showing 1 - 6 results of 6 for search 'Brian Porter', query time: 0.04s Refine Results
  1. 1
    The Birth of the "Polak-Katolik"

    The Birth of the "Polak-Katolik" by Brian Porter-Szűcs

    Published 2017-12-01
    Get full text
    Article
  2. 2
    Efficacy, safety, and tolerability of secukinumab in patients with active ankylosing spondylitis: a randomized, double-blind phase 3 study, MEASURE 3

    Efficacy, safety, and tolerability of secukinumab in patients with active ankylosing spondylitis: a randomized, double-blind phase 3 study, MEASURE 3 by Karel Pavelka, Alan Kivitz, Eva Dokoupilova, Ricardo Blanco, Marco Maradiaga, Hasan Tahir, Luminita Pricop, Mats Andersson, Aimee Readie, Brian Porter

    Published 2017-12-01
    Get full text
    Article
  3. 3
    Safety of Secukinumab from 1 Million Patient-Years of Exposure: Experience from Post-Marketing Setting and Clinical Trials

    Safety of Secukinumab from 1 Million Patient-Years of Exposure: Experience from Post-Marketing Setting and Clinical Trials by Rui Sun, Mercedes Bustamante, Venkatesh Kumar Gurusamy, Mark Lebwohl, Alice B. Gottlieb, Philip J. Mease, Atul Deodhar, Weibin Bao, Meryl Mendelson, Brian Porter, Deepa Chand, Victor Dong

    Published 2024-03-01
    Get full text
    Article
  4. 4
    Incidence of Uveitis in Secukinumab‐treated Patients With Ankylosing Spondylitis: Pooled Data Analysis From Three Phase 3 Studies

    Incidence of Uveitis in Secukinumab‐treated Patients With Ankylosing Spondylitis: Pooled Data Analysis From Three Phase 3 Studies by Atul A. Deodhar, Corine Miceli‐Richard, Xenofon Baraliakos, Helena Marzo‐Ortega, Dafna D. Gladman, Ricardo Blanco, Ayan Das Gupta, Ruvie Martin, Jorge Safi Jr, Brian Porter, Abhijit Shete, James T. Rosenbaum

    Published 2020-05-01
    Get full text
    Article
  5. 5
    Secukinumab provided significant and sustained improvement in the signs and symptoms of ankylosing spondylitis: results from the 52-week, Phase III China-centric study, MEASURE 5

    Secukinumab provided significant and sustained improvement in the signs and symptoms of ankylosing spondylitis: results from the 52-week, Phase III China-centric study, MEASURE 5 by Feng Huang, Fei Sun, Wei-Guo Wan, Li-Jun Wu, Ling-Li Dong, Xiao Zhang, Tae-Hwan Kim, Raj Sengupta, Ladislav Šenolt, Yi Wang, Hao-Min Qiu, Brian Porter, Sibylle Haemmerle, Li-Shao Guo

    Published 2020-11-01
    Get full text
    Article
  6. 6
    Comprehensive nodal breast VMAT: solving the low‐dose wash dilemma using an iterative knowledge‐based radiotherapy planning solution

    Comprehensive nodal breast VMAT: solving the low‐dose wash dilemma using an iterative knowledge‐based radiotherapy planning solution by Cameron Stanton, Linda J. Bell, Andrew Le, Brooke Griffiths, Kenny Wu, Jessica Adams, Leigh Ambrose, Denise Andree‐Evarts, Brian Porter, Regina Bromley, Kirsten vanGysen, Marita Morgia, Gillian Lamoury, Thomas Eade, Jeremy T. Booth, Susan Carroll

    Published 2022-03-01
    Get full text
    Article

Search Tools: